Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan

Published:2022-04-06 Issue:6 Volume:26 Page:1065-1078
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Nangaku Masaomi¹,Akizawa Tadao²^ORCID,Nagakubo Takashi³,Yonekawa Taeko⁴,Kimura Toshifumi⁵^ORCID,Endo Yukihiro⁴,Cobitz Alexander⁶

Affiliation:

1. Division of Nephrology and Endocrinology The University of Tokyo Graduate School of Medicine Tokyo Japan

2. Division of Nephrology, Department of Medicine Showa University School of Medicine Tokyo Japan

3. Biostatistics GlaxoSmithKline Tokyo Japan

4. Medicines Development GlaxoSmithKline Tokyo Japan

5. Medical Affairs GlaxoSmithKline Tokyo Japan

6. Clinical Sciences GlaxoSmithKline Collegeville Pennsylvania USA

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.13839

Reference41 articles.

1. Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018

2. ESA, Iron Therapy and New Drugs: Are There New Perspectives in the Treatment of Anaemia?

3. Framing Cause-Effect Relationship of Acute Coronary Syndrome in Patients with Chronic Kidney Disease

4. 2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

5. Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renoprotective Effects of Daprodustat in Patients with Chronic Kidney Disease and Renal Anemia;International Journal of Molecular Sciences;2024-08-30

2. Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association;Nephrology Dialysis Transplantation;2024-04-04

3. The Comparison between Vadadustat and Daprodustat Regarding Dose, Cost, and Safety of Treatment for Renal Anemia in Non-dialysis Patients with Chronic Kidney Diseases;Internal Medicine;2024

4. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism;International Journal of Molecular Sciences;2023-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3